Riggs Asset Management’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-50
| Closed | -$148 | – | 678 |
|
|
2024
Q2 | $148 | Hold |
50
| – | – | ﹤0.01% | 639 |
|
|
2024
Q1 | $147 | Hold |
50
| – | – | ﹤0.01% | 639 |
|
|
2023
Q4 | $125 | Hold |
50
| – | – | ﹤0.01% | 411 |
|
|
2023
Q3 | $156 | Hold |
50
| – | – | ﹤0.01% | 406 |
|
|
2023
Q2 | $230 | Hold |
50
| – | – | ﹤0.01% | 378 |
|
|
2023
Q1 | $355 | Hold |
50
| – | – | ﹤0.01% | 351 |
|
|
2022
Q4 | $321 | Hold |
50
| – | – | ﹤0.01% | 318 |
|
|
2022
Q3 | $1K | Hold |
50
| – | – | ﹤0.01% | 308 |
|
|
2022
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 289 |
|
|
2022
Q1 | $1K | Hold |
50
| – | – | ﹤0.01% | 304 |
|
|
2021
Q4 | $2K | Hold |
50
| – | – | ﹤0.01% | 299 |
|
|
2021
Q3 | $4K | Hold |
50
| – | – | ﹤0.01% | 277 |
|
|
2021
Q2 | $6K | Hold |
50
| – | – | ﹤0.01% | 253 |
|
|
2021
Q1 | $5K | Hold |
50
| – | – | ﹤0.01% | 237 |
|
|
2020
Q4 | $2K | Buy |
+50
| New | +$2K | ﹤0.01% | 252 |
|
|
2020
Q3 | – | Sell |
-50
| Closed | -$1K | – | 223 |
|
|
2020
Q2 | $1K | Hold |
50
| – | – | ﹤0.01% | 236 |
|
|
2020
Q1 | $2K | Hold |
50
| – | – | ﹤0.01% | 230 |
|
|
2019
Q4 | $2K | Sell |
50
-100
| -67% | -$4K | ﹤0.01% | 264 |
|
|
2019
Q3 | $6K | Sell |
150
-15
| -9% | -$600 | ﹤0.01% | 192 |
|
|
2019
Q2 | $8K | Hold |
165
| – | – | ﹤0.01% | 189 |
|
|
2019
Q1 | $13K | Buy |
+165
| New | +$13K | 0.01% | 168 |
|